top of page

See if You Qualify

Eligibility

  • Documented diagnosis of Prader-Willi syndrome (PWS)

  • Age 10 years old or older

  • Primary carer that can commit to the trial requirements for 12 weeks

Study Details

  • Eligible participants will either receive investigational medication or placebo (no active investigational medication ingredients)

  • Investigational medication will be taken orally twice daily for 12 weeks

  • Approximately 4 in-person visits and 3 telehealth visits are required

  • Travel and accommodation (if required) for the participant and a primary carer will be covered

  • No fasting required

  • All participants who complete the HERO study will have the option to participate in a follow-up study where everyone will receive the investigational medication

Study Locations

  • Find the clinical centre nearest you

Get Help to Participate Form
bottom of page